The estimated Net Worth of George Hrenko is at least $2.54 Million dollars as of 27 February 2017. George Hrenko owns over 126,043 units of HeartBeam Inc stock worth over $52,691 and over the last 11 years George sold BEAT stock worth over $2,482,678.
George has made over 13 trades of the HeartBeam Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently George exercised 126,043 units of BEAT stock worth $637,778 on 27 February 2017.
The largest trade George's ever made was exercising 126,043 units of HeartBeam Inc stock on 27 February 2017 worth over $637,778. On average, George trades about 11,771 units every 9 days since 2014. As of 27 February 2017 George still owns at least 23,418 units of HeartBeam Inc stock.
You can see the complete history of George Hrenko stock trades at the bottom of the page.
George's mailing address filed with the SEC is 1000 CEDAR HOLLOW RD, , MALVERN, PA, 19355.
Over the last 11 years, insiders at HeartBeam Inc have traded over $23,124,978 worth of HeartBeam Inc stock and bought 31,500 units worth $221,145 . The most active insiders traders include Joseph H Capper, Heather C Getz, and Willem Elfrink. On average, HeartBeam Inc executives and independent directors trade stock every 32 days with the average trade being worth of $55,046. The most recent stock trade was executed by Urioste George De on 6 September 2024, trading 1,674 units of BEAT stock currently worth $3,917.
heartbeam developed a mhealth technology that is diagnostically equivalent to a cardiologist reading a patient’s 12 lead ecg and examining the patient. it comprises a credit card size, 12 lead equivalent, ecg device and a cloud-based diagnostic expert system. studies designed by harvard medical school faculty have shown heartbeam performance to be equal or better than world class cardiologists in diagnosing a heart attack. the technology features personalized diagnostic thresholds and novel heart attack ecg markers from which the application can also help cardiologists locate a heart attack on a 3d model of the heart. heartbeam's icardiologist application utilizes artificial intelligence / machine learning to drive continuous improvements of the system's ability to provide patient analysis and improve the solution's predictive properties.
HeartBeam Inc executives and other stock owners filed with the SEC include: